These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 10769068)

  • 1. CD8(+) cell noncytotoxic anti-human immunodeficiency virus response inhibits expression of viral RNA but not reverse transcription or provirus integration.
    Mackewicz CE; Patterson BK; Lee SA; Levy JA
    J Gen Virol; 2000 May; 81(Pt 5):1261-4. PubMed ID: 10769068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
    Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M
    J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.
    Chun TW; Carruth L; Finzi D; Shen X; DiGiuseppe JA; Taylor H; Hermankova M; Chadwick K; Margolick J; Quinn TC; Kuo YH; Brookmeyer R; Zeiger MA; Barditch-Crovo P; Siliciano RF
    Nature; 1997 May; 387(6629):183-8. PubMed ID: 9144289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derivation of infectious HIV-1 molecular clones with LTR mutations: sensitivity to the CD8+ cell noncytotoxic anti-HIV response.
    Bonneau KR; Ng S; Foster H; Choi KB; Berkhout B; Rabson A; Mackewicz CE; Levy JA
    Virology; 2008 Mar; 373(1):30-8. PubMed ID: 18086484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies.
    Chun TW; Justement JS; Moir S; Hallahan CW; Ehler LA; Liu S; McLaughlin M; Dybul M; Mican JM; Fauci AS
    Proc Natl Acad Sci U S A; 2001 Jan; 98(1):253-8. PubMed ID: 11136258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Entry and transcription as key determinants of differences in CD4 T-cell permissiveness to human immunodeficiency virus type 1 infection.
    Ciuffi A; Bleiber G; Muñoz M; Martinez R; Loeuillet C; Rehr M; Fischer M; Günthard HF; Oxenius A; Meylan P; Bonhoeffer S; Trono D; Telenti A
    J Virol; 2004 Oct; 78(19):10747-54. PubMed ID: 15367641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8+ cell-derived anti-human immunodeficiency virus inhibitory factor.
    Barker E
    J Infect Dis; 1999 May; 179 Suppl 3():S485-8. PubMed ID: 10099125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD8(+)-Cell antiviral factor activity is not restricted to human immunodeficiency virus (HIV)-specific T cells and can block HIV replication after initiation of reverse transcription.
    Le Borgne S; Février M; Callebaut C; Lee SP; Rivière Y
    J Virol; 2000 May; 74(10):4456-64. PubMed ID: 10775581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro induction of HIV-1 replication in resting CD4(+) T cells derived from individuals with undetectable plasma viremia upon stimulation with human T-cell leukemia virus type I.
    Moriuchi H; Moriuchi M
    Virology; 2000 Dec; 278(2):514-9. PubMed ID: 11118373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD8+ T cells suppress human immunodeficiency virus replication by inhibiting viral transcription.
    Mackewicz CE; Blackbourn DJ; Levy JA
    Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2308-12. PubMed ID: 7534418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gradual shutdown of virus production resulting in latency is the norm during the chronic phase of human immunodeficiency virus replication and differential rates and mechanisms of shutdown are determined by viral sequences.
    Li XD; Moore B; Cloyd MW
    Virology; 1996 Nov; 225(1):196-212. PubMed ID: 8918547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-9 receptor alpha chain mRNA formation in CD8+ T cells producing anti-human immunodeficiency virus type 1 substance(s).
    Hossain MM; Tsuchie H; Detorio MA; Shirono H; Hara C; Nishimoto A; Saji A; Koga J; Takata N; Maniar JK; Saple DG; Taniguchi K; Kageyama S; Ichimura H; Kurimura T
    Acta Virol; 1998 Feb; 42(1):47-53. PubMed ID: 9645243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A lentiviral vector that activates latent human immunodeficiency virus-1 proviruses by the overexpression of tat and that kills the infected cells.
    Macías D; Oya R; Saniger L; Martín F; Luque F
    Hum Gene Ther; 2009 Nov; 20(11):1259-68. PubMed ID: 19604078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection of the CD45RA+ (naive) subset of peripheral CD8+ lymphocytes by human immunodeficiency virus type 1 in vivo.
    McBreen S; Imlach S; Shirafuji T; Scott GR; Leen C; Bell JE; Simmonds P
    J Virol; 2001 May; 75(9):4091-102. PubMed ID: 11287558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in the viral mRNA expression pattern correlate with a rapid rate of CD4+ T-cell number decline in human immunodeficiency virus type 1-infected individuals.
    Furtado MR; Kingsley LA; Wolinsky SM
    J Virol; 1995 Apr; 69(4):2092-2100. PubMed ID: 7884855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual phasic suppression of viral replication following de novo human immunodeficiency virus type 1 (HIV-1) infection in lymphocytes of asymptomatic HIV-1 carriers.
    Kannagi M; Nakamura T; Akari H; Kuroda MJ; Fujii M; Oka S; Iwamoto A; Kurata T; Higashi D; Harada S
    Leukemia; 1997 Apr; 11 Suppl 3():545-7. PubMed ID: 9209452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual role of prostratin in inhibition of infection and reactivation of human immunodeficiency virus from latency in primary blood lymphocytes and lymphoid tissue.
    Biancotto A; Grivel JC; Gondois-Rey F; Bettendroffer L; Vigne R; Brown S; Margolis LB; Hirsch I
    J Virol; 2004 Oct; 78(19):10507-15. PubMed ID: 15367617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of human immunodeficiency virus type 1 decay following entry into resting CD4+ T cells.
    Zhou Y; Zhang H; Siliciano JD; Siliciano RF
    J Virol; 2005 Feb; 79(4):2199-210. PubMed ID: 15681422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for human immunodeficiency virus type 1 replication in vivo in CD14(+) monocytes and its potential role as a source of virus in patients on highly active antiretroviral therapy.
    Zhu T; Muthui D; Holte S; Nickle D; Feng F; Brodie S; Hwangbo Y; Mullins JI; Corey L
    J Virol; 2002 Jan; 76(2):707-16. PubMed ID: 11752161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro.
    Spina CA; Guatelli JC; Richman DD
    J Virol; 1995 May; 69(5):2977-88. PubMed ID: 7707524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.